ATE279386T1 - Retinoide zur behandlung von emphysem - Google Patents

Retinoide zur behandlung von emphysem

Info

Publication number
ATE279386T1
ATE279386T1 AT00951439T AT00951439T ATE279386T1 AT E279386 T1 ATE279386 T1 AT E279386T1 AT 00951439 T AT00951439 T AT 00951439T AT 00951439 T AT00951439 T AT 00951439T AT E279386 T1 ATE279386 T1 AT E279386T1
Authority
AT
Austria
Prior art keywords
retinoids
emphysema
treatment
Prior art date
Application number
AT00951439T
Other languages
English (en)
Inventor
Paula Nanette Belloni
Michael Klaus
Jean-Marc Lapierre
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE279386T1 publication Critical patent/ATE279386T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/28—Unsaturated compounds polycyclic
    • C07C61/29—Unsaturated compounds polycyclic having a carboxyl group bound to a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/66—Polycyclic acids with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/753—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of polycyclic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00951439T 1999-08-02 2000-07-25 Retinoide zur behandlung von emphysem ATE279386T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99115223 1999-08-02
PCT/EP2000/007091 WO2001009076A2 (en) 1999-08-02 2000-07-25 Retinoids for the treatment of emphysema

Publications (1)

Publication Number Publication Date
ATE279386T1 true ATE279386T1 (de) 2004-10-15

Family

ID=8238709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00951439T ATE279386T1 (de) 1999-08-02 2000-07-25 Retinoide zur behandlung von emphysem

Country Status (18)

Country Link
US (3) US6528677B1 (de)
EP (1) EP1206436B1 (de)
JP (1) JP3961827B2 (de)
KR (1) KR100466730B1 (de)
CN (1) CN1166618C (de)
AR (1) AR024998A1 (de)
AT (1) ATE279386T1 (de)
AU (1) AU772551B2 (de)
BR (1) BR0012951A (de)
CA (1) CA2386793C (de)
DE (1) DE60014928T2 (de)
DK (1) DK1206436T3 (de)
ES (1) ES2228587T3 (de)
MX (1) MXPA02000828A (de)
PT (1) PT1206436E (de)
TR (1) TR200200263T2 (de)
WO (1) WO2001009076A2 (de)
ZA (1) ZA200200516B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2178B1 (en) * 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of emphysema using rar selective retinoid antagonists
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US7914437B2 (en) * 2005-02-04 2011-03-29 Ams Research Corporation Transobturator methods for installing sling to treat incontinence, and related devices
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
EP2190429B1 (de) 2007-09-10 2016-04-20 Boston Biomedical, Inc. Neue gruppe von stat3-pfad-hemmern und krebs-stammzell-pfad-hemmer
DK2547205T3 (da) 2010-03-19 2024-05-27 1Globe Biomedical Co Ltd Hidtil ukendte fremgangsmåder til målretning mod cancerstamceller
US8772273B2 (en) * 2011-10-04 2014-07-08 Quretino Therapeutics, Inc. Formulations and uses of retinoic acid receptor selective agonists
CA2856703A1 (en) 2011-10-19 2013-04-25 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
US20160030384A1 (en) 2013-04-09 2016-02-04 Boston Biomedical, Inc. 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer
DK3102576T3 (da) 2014-02-03 2019-07-22 Vitae Pharmaceuticals Llc Dihydropyrrolopyridininhibitorer af ror-gamma
SI3207043T1 (sl) 2014-10-14 2019-04-30 Vitae Pharmaceuticals, Inc. Dihidropirolopiridinovi inhibitorji za ROR-gama
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
EP3331876B1 (de) 2015-08-05 2020-10-07 Vitae Pharmaceuticals, LLC Modulatoren von ror-gamma
EP3868750A1 (de) 2015-11-20 2021-08-25 Vitae Pharmaceuticals, LLC Modulatoren von ror-gamma
TWI757266B (zh) 2016-01-29 2022-03-11 美商維它藥物有限責任公司 ROR-γ調節劑
CA3045306A1 (en) 2016-11-29 2018-06-07 Boston Biomedical, Inc. Naphthofuran derivatives, preparation, and methods of use thereof
JP2020520923A (ja) 2017-05-17 2020-07-16 ボストン バイオメディカル, インコーポレイテッド がんを処置するための方法
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA
CN115716826A (zh) 2017-07-24 2023-02-28 生命医药有限责任公司 RORγ的抑制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87821A1 (fr) * 1990-10-12 1992-05-25 Cird Galderma Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique
US5958954A (en) * 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Also Published As

Publication number Publication date
ZA200200516B (en) 2003-06-25
AR024998A1 (es) 2002-11-06
US20030176726A1 (en) 2003-09-18
WO2001009076A3 (en) 2001-07-19
CA2386793C (en) 2006-03-28
TR200200263T2 (tr) 2004-12-21
US6528677B1 (en) 2003-03-04
US20050113447A1 (en) 2005-05-26
ES2228587T3 (es) 2005-04-16
JP2003526626A (ja) 2003-09-09
AU772551B2 (en) 2004-04-29
KR100466730B1 (ko) 2005-01-24
PT1206436E (pt) 2004-12-31
EP1206436B1 (de) 2004-10-13
DK1206436T3 (da) 2005-02-14
MXPA02000828A (es) 2002-07-30
DE60014928D1 (de) 2004-11-18
KR20020030089A (ko) 2002-04-22
EP1206436A2 (de) 2002-05-22
WO2001009076A2 (en) 2001-02-08
CN1166618C (zh) 2004-09-15
CA2386793A1 (en) 2001-02-08
BR0012951A (pt) 2002-04-30
DE60014928T2 (de) 2006-03-09
US6828337B2 (en) 2004-12-07
AU6437300A (en) 2001-02-19
JP3961827B2 (ja) 2007-08-22
CN1368946A (zh) 2002-09-11

Similar Documents

Publication Publication Date Title
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE413375T1 (de) Retinoide zur behandlung von emphysem
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE69936890D1 (de) Vorrichtung zur Behandlung von Ischämie
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
ATE247987T1 (de) Behandlung zur beseitigung von gerüchen
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
ATE451921T1 (de) Phenylindole zur behandlung von hiv
ATE269303T1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60029033D1 (de) Verfahren zur Behandlung von Tissuepapier
DE60014928D1 (de) Retinoide zur behandlung von emphysem
ATE254913T1 (de) Diacerein zur behandlung von psoriasis
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
ATE344661T1 (de) Rar-gamma selektive retinoid-agonisten zur behandlung von emphysemen
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
EP1117431A4 (de) Behandlung von acidose
DE60224650D1 (de) Vorrichtung zur behandlung von vorhof-fibrillation
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1206436

Country of ref document: EP

REN Ceased due to non-payment of the annual fee